» Articles » PMID: 1245780

Radioimmunoassay of Human C-reactive Protein and Levels in Normal Sera

Overview
Journal J Lab Clin Med
Publisher Elsevier
Date 1976 Jan 1
PMID 1245780
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

C-reactive protein (CRP) has been considered an acute-phase protein which appears only during reactions of tissue injury or inflammation. We report here the quantitation of CRP levels in normal adults and neonates made possible by the development of a sensitive and precise radioimmunoassay for human CRP which enables the detection of 3 ng. per milliliter. Serum levels in 153 healthy blood donors ranged from 68 to 8,200 ng. per milliliter, with a median value of 580 ng. per milliliter (mean = 1,340 ng. per milliliter). CRP levels in 24 normal cord serum samples ranged from 10 to 370 ng. per milliliter, with a median value of 70 ng. per milliliter (mean = 109 ng. per milliliter). CRP levels in 246 individuals evaluated for autoimmune diseases ranged to 256,000 ng. per milliliter with a median value of 13,000 ng. per milliliter (mean = 38,000 ng. per milliliter). No individual lacking CRP was detected. Thus, CRP can be considered a component of normal serum which only increases dramatically in concentration during inflammation.

Citing Articles

C-reactive Protein Kinetics During In-Patient Treatment of COVID-19-Associated Rhino-Orbito-Cerebral Mucormycosis: A Retrospective Cohort Study in a Tertiary Hospital in Central India.

B H S, Bidkar V, Prathipati K, Dabhekar S, Selvaraj K, G D Cureus. 2024; 16(4):e59007.

PMID: 38800245 PMC: 11127724. DOI: 10.7759/cureus.59007.


A Low-Cost Microfluidic-Based Detection Device for Rapid Identification and Quantification of Biomarkers-Based on a Smartphone.

Yang C, Yang Y, Zhao G, Wang H, Dai Y, Huang X Biosensors (Basel). 2023; 13(7).

PMID: 37504151 PMC: 10377552. DOI: 10.3390/bios13070753.


C-reactive protein - My perspective on its first half century, 1930-1982.

Kushner I Front Immunol. 2023; 14:1150103.

PMID: 36936978 PMC: 10018134. DOI: 10.3389/fimmu.2023.1150103.


Tuberculosis screening improves preventive therapy uptake (TB SCRIPT) trial among people living with HIV in Uganda: a study protocol of an individual randomized controlled trial.

Semitala F, Chaisson L, Dowdy D, Armstrong D, Opira B, Aman K Trials. 2022; 23(1):399.

PMID: 35550621 PMC: 9096738. DOI: 10.1186/s13063-022-06371-0.


Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis.

Dhana A, Hamada Y, Kengne A, Kerkhoff A, Rangaka M, Kredo T Lancet Infect Dis. 2021; 22(4):507-518.

PMID: 34800394 PMC: 8942858. DOI: 10.1016/S1473-3099(21)00387-X.